Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Cash Flows (unaudited)

v3.21.2
Condensed Statement of Cash Flows (unaudited)
9 Months Ended
Sep. 30, 2021
USD ($)
OPERATING ACTIVITIES  
Net loss $ (4,280,092)
Adjustments to reconcile net loss to net cash used in operating activities:  
Change in fair value of warrant liability 196,973
Interest earned on cash and marketable securities held in Trust Account (20,160)
Change in operating assets and liabilities:  
Prepaid expenses (347,674)
Receivable from related party (1,242)
Other long-term assets (114,487)
Accounts payable 2,396
Payable to related parties 57,369
Accrued liabilities 2,232,049
Other current liabilities 6,016
Net cash used in operating activities (2,268,852)
INVESTING ACTIVITIES  
Investment of cash in Trust Account (358,800,000)
Net cash used in investing activities (358,800,000)
FINANCING ACTIVITIES  
Proceeds from sale of Units, net of underwriting discounts paid 351,624,000
Repayment of borrowing from a related party (125,000)
Payment of offering costs (593,899)
Net cash provided by financing activities 361,901,101
Net increase in cash during period 832,249
Cash, beginning of period 150,000
Cash, end of period 982,249
Offering costs included in accrued liabilities 70,000
Fair value of warrant liability 187,908
Deferred underwriting fee payable 12,558,000
Change in value of common stock subject to possible redemption 20,412,043
Underwriters  
FINANCING ACTIVITIES  
Proceeds from sale of Private Placement Units 2,496,000
Payment of offering costs (7,176,000)
Founder [Member]  
FINANCING ACTIVITIES  
Proceeds from sale of Private Placement Units $ 8,500,000